The DOI matches its Crossref record; 52 of the 53 references it cites were found in a registry or an index.
Evolution of the neuropathology of Alzheimer's disease
Abstract
Our knowledge of the etiology and pathogenesis of Alzheimer's disease is limited. The most conspicuous changes seen in the brain are deposits of insoluble proteins in both extracellular and intraneuronal locations. The extracellular deposits consist primarily of a specific A4 amyloid protein. The significance of these deposits remains to be determined, as they are often found in the cerebral cortex of non-demented elderly persons. More telling is the gradual accumulation of insoluble fibrous material within some neurons that consists mainly of abnormally phosphorylated tau protein. Six stages of increasingly severe cortical destruction can be distinguished. Stages I and II are characterized by neurofibrillary changes that are largely confined to the transentorhinal region, whereas stages III and IV are marked by severe involvement of both the entorhinal and transentorhinal regions. Isocortical destruction occurs during stages V and VI. This progression in cortical pathology correlates with the gradual worsening of clinical symptoms.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“We focused our analysis on the HIC and associated cortices because these structures are known to be affected early in AD26.”
From Resilience to autosomal dominant Alzheimer’s disease in a Reelin-COLBOS heterozygous man (2023) · cites this paper as [26]
In the citing paper
“The hippocampus is not, however, a unitary anatomical formation. Several subfields have been identified, which can be differentiated on both histological grounds [2], [8] and according to their functional role in memory encoding and retrieval [9], [10].”
From Atrophy of presubiculum and subiculum is the earliest hippocampal anatomical marker of Alzheimer's disease (2015) · cites this paper as [2]
In the citing paper
“Neuropathological changes in patients with Alzheimer's disease (AD) typically affect the hippocampal formation very early [1], [2].”
From Atrophy of presubiculum and subiculum is the earliest hippocampal anatomical marker of Alzheimer's disease (2015) · cites this paper as [2]
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Self-citationDistributed hierarchical processing in the primate cerebral cortex
Felleman, D. J., & Van Essen, D. C. (1991) · Cerebral Cortex · doi:10.1093/cercor/1.1.1 · Cited by 7,783
Memory and the hippocampus: A synthesis from findings with rats, monkeys, and humans.
Squire, L. R. (1992) · Psychological Review · doi:10.1037/0033-295x.99.2.195 · Cited by 5,376
Mirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961
Grundke-Iqbal, I., Iqbal, K., Tung, Y. C., Quinlan, M., Wisniewski, H. M., & Binder, L. I. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.13.4913 · Cited by 3,676
Preface: Cerebral Cortex Has Come of Age
Goldman, P. S., & RAKIC, P. T. (1991) · Cerebral Cortex · doi:10.1093/cercor/1.1.1-a · Cited by 3,537
Diagnosis of Alzheimer's Disease
Khachaturian, Z. S. (1985) · Archives of Neurology · doi:10.1001/archneur.1985.04060100083029 · Cited by 2,499
Staging of alzheimer's disease-related neurofibrillary changes
Braak, H., & Braak, E. (1995) · Neurobiology of Aging · doi:10.1016/0197-4580(95)00021-6 · Cited by 2,357
Self-citationAlzheimer's disease: cell-specific pathology isolates the hippocampal formation.
Hyman, B. T., Van Hoesen, G. W., Damasio, A. R., & Barnes, C. L. (1984) · Science · doi:10.1126/science.6474172 · Cited by 2,268
Functional Assessment Staging (FAST)
Gauthier, S. G. (2001) · CRC Press eBooks · doi:10.3109/9780203213896-33 · Cited by 1,023
Research works printed but not linked: 2
- Kemper, 1978, Senile dementia: a biomedical approach, 105
- Braak, 1993, Alzheimer's disease: advances in clinical and basic research. Third International Conference on Alzheimer's Disease and Related Disorders, 131
Cited by
Sorted by citations
Ageing as a risk factor for neurodegenerative disease
Hou, Y., Dan, X., Babbar, M., Wei, Y., Hasselbalch, S. G., Croteau, D. L., & Bohr, V. A. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-019-0244-7 · Cited by 3,310
Harada, C. N., Love, M. C. N., & Triebel, K. L. (2013) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2013.07.002 · Cited by 2,649
Use of Florbetapir-PET for Imaging β-Amyloid Pathology
Clark, C. M. (2011) · JAMA · doi:10.1001/jama.2010.2008 · Cited by 1,117
Verbal fluency performance in dementia of the Alzheimer’s type: a meta-analysis
Henry, J. D., Crawford, J. R., & Phillips, L. H. (2004) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2004.02.001 · Cited by 847
Quantitative gait dysfunction and risk of cognitive decline and dementia
Verghese, J., Wang, C., Lipton, R. B., Holtzer, R., & Xue, X. (2007) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2006.106914 · Cited by 797
History and progress of hypotheses and clinical trials for Alzheimer’s disease
Liu, P.-P., Xie, Y., Meng, X.-Y., & Kang, J.-S. (2019) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-019-0063-8 · Cited by 723
Alzheimer's disease drug development pipeline: 2018
Cummings, J., Lee, G., Ritter, A., & Zhong, K. (2018) · Alzheimer's & Dementia: Translational Research & Clinical Interventions · doi:10.1016/j.trci.2018.03.009 · Cited by 697
Whitwell, J. L., Przybelski, S. A., Weigand, S. D., Knopman, D. S., Boeve, B. F., Petersen, R. C., & Jack, C. R. (2007) · Brain · doi:10.1093/brain/awm112 · Cited by 607
The Neuropsychological Profile of Alzheimer DiseasePreprint
Weıntraub, S., Wicklund, A. H., & Salmon, D. P. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006171 · Cited by 638
Alzheimer and frontotemporal pathology in subsets of primary progressive aphasia
Mesulam, M., Wicklund, A., Johnson, N., Rogalski, E., Léger, G. C., Rademaker, A., Weintraub, S., & Bigio, E. H. (2008) · Annals of Neurology · doi:10.1002/ana.21388 · Cited by 513
Bahar-Fuchs, A., Clare, L., & Woods, B. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003260.pub2 · Cited by 507
Primary Progressive Aphasia — A Language-Based Dementia
Mesulam, M. M. (2003) · New England Journal of Medicine · doi:10.1056/nejmra022435 · Cited by 471
The hippocampus in aging and disease: From plasticity to vulnerability
Bartsch, T., & Wulff, P. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.07.084 · Cited by 499
Advances in the early detection of Alzheimer's disease
Nestor, P. J., Scheltens, P., & Hodges, J. R. (2004) · Nature Medicine · doi:10.1038/nrn1433 · Cited by 480
Neuroplasticity Failure in Alzheimer's Disease
Mesulam, M.-M. (1999) · Neuron · doi:10.1016/s0896-6273(00)81109-5 · Cited by 449
Model‐guided microarray implicates the retromer complex in Alzheimer's disease
Small, S. A., Kent, K., Pierce, A., Leung, C., Kang, M. S., Okada, H., Honig, L., Vonsattel, J., & Kim, T. (2005) · Annals of Neurology · doi:10.1002/ana.20667 · Cited by 440
Early diagnosis of alzheimer’s disease: contribution of structural neuroimaging
Chételat, G., & Baron, J. (2003) · NeuroImage · doi:10.1016/s1053-8119(02)00026-5 · Cited by 455
Hallucinations, REM sleep, and Parkinson’s disease
Arnulf, I., Bonnet, A.-M., Damier, P., Bejjani, B.-P. W., Seilhean, D., Derenne, J., & Agid, Y. (2000) · Neurology · doi:10.1212/wnl.55.2.281 · Cited by 439
The Neuropharmacological Basis for the Use of Memantine in the Treatment of Alzheimer's Disease
Rogawski, M. A., & Wenk, G. L. (2003) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2003.tb00254.x · Cited by 449
Focal Decline of Cortical Thickness in Alzheimer's Disease Identified by Computational Neuroanatomy
Lerch, J. P., Pruessner, J. C., Zijdenbos, A. P., Hampel, H. J., Teipel, S. J., & Evans, A. C. (2004) · Cerebral Cortex · doi:10.1093/cercor/bhh200 · Cited by 447
Good, C. D., Scahill, R. I., Fox, N. C., Ashburner, J., Friston, K. J., Chan, D., Crum, W. R., Rossor, M. N., & Frackowiak, R. S. J. (2002) · NeuroImage · doi:10.1006/nimg.2002.1202 · Cited by 415
Bubu, O. M., Andrade, A. G., Umasabor-Bubu, O. Q., Hogan, M. M., Turner, A. D., de Leon, M. J., Ogedegbe, G., Ayappa, I., Jean-Louis G, G., Jackson, M. L., et al. (2020) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2019.101250 · Cited by 389
Grudzien, A., Shaw, P., Weintraub, S., Bigio, E., Mash, D. C., & Mesulam, M. M. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.02.007 · Cited by 396
Microtubule-associated protein tau in development, degeneration and protection of neurons
Wang, J., & Liu, F. (2008) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2008.03.002 · Cited by 405
Primary progressive aphasia and the evolving neurology of the language network
Mesulam, M. M., Rogalski, E. J., Wieneke, C., Hurley, R. S. E., Geula, C., Bigio, E. H., Thompson, C. K., & Weıntraub, S. (2014) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.159 · Cited by 406
Joshi, A. D., Pontecorvo, M. J., Clark, C. M., Carpenter, A. P., Jennings, D. L., Sadowsky, C., Adler, L. P., Kovnat, K. D., Seibyl, J. P., Arora, A., et al. (2012) · Journal of Nuclear Medicine · doi:10.2967/jnumed.111.090340 · Cited by 401
Do Corticosteroids Damage the Brain?
Herbert, J., Goodyer, I. M., Grossman, A. B., Hastings, M. H., de Kloet, E. R., Lightman, S. L., LUPIEN, S. J., Roozendaal, B., & Seckl, J. R. (2006) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2006.01429.x · Cited by 398
Cholinergic circuitry of the human nucleus basalis and its fate in Alzheimer's disease
Mesulam, M. M. (2013) · The Journal of Comparative Neurology · doi:10.1002/cne.23415 · Cited by 382
MRI correlates of neurofibrillary tangle pathology at autopsy: A voxel-based morphometry study
Whitwell, J. L., Josephs, K. A., Murray, M. E., Kantarci, K., Przybelski, S. A., Weigand, S. D., Vemuri, P., Senjem, M. L., Parisi, J. E., Knopman, D. S., et al. (2008) · Neurology · doi:10.1212/01.wnl.0000324924.91351.7d · Cited by 376
Cholinergic nucleus basalis tauopathy emerges early in the aging‐MCI‐AD continuum
Mesulam, M. M., Shaw, P. L., Mash, D. C., & Weıntraub, S. (2004) · Annals of Neurology · doi:10.1002/ana.20100 · Cited by 365
Patterns of Cognitive Decline in Presymptomatic Alzheimer Disease
Chen, P., Ratcliff, G. G., Belle, S. H., Cauley, J. A., DeKosky, S. T., & Ganguli, M. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.9.853 · Cited by 369
Fleisher, A. S. (2011) · Archives of Neurology · doi:10.1001/archneurol.2011.150 · Cited by 364
MRI patterns of atrophy associated with progression to AD in amnestic mild cognitive impairment
Whitwell, J. L., Shiung, M. M., Przybelski, S. A., Weigand, S. D., Knopman, D. S., Boeve, B. F., Petersen, R. C., & Jack, C. R. (2008) · Neurology · doi:10.1212/01.wnl.0000280575.77437.a2 · Cited by 357
Lithfous, S., Dufour, A., & Després, O. (2012) · Ageing Research Reviews · doi:10.1016/j.arr.2012.04.007 · Cited by 385
Focal atrophy in dementia with Lewy bodies on MRI: a distinct pattern from Alzheimer's disease
Whitwell, J. L., Weigand, S. D., Shiung, M. M., Boeve, B. F., Ferman, T. J., Smith, G. E., Knopman, D. S., Petersen, R. C., Benarroch, E. E., Josephs, K. A., et al. (2007) · Brain · doi:10.1093/brain/awl388 · Cited by 354
The role of 5-HT1A receptors in learning and memory
Ögren, S. O., Eriksson, T. M., Elvander-Tottie, E., D’Addario, C., Ekstrom, J. C., Svenningsson, P., Meister, B., Kehr, J., & Stiedl, O. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.02.023 · Cited by 348
Cognitive training for people with mild to moderate dementia
Bahar-Fuchs, A., Martyr, A., Goh, A. M., Sabates, J., & Clare, L. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013069.pub2 · Cited by 342
Direct voxel-based comparison between grey matter hypometabolism and atrophy in Alzheimer's disease
Chételat, G., Desgranges, B., Landeau, B., Mézenge, F., Poline, J.-B., Sayette, V. D. L., Viader, F., Eustache, F., & Baron, J. (2007) · Brain · doi:10.1093/brain/awm288 · Cited by 349
Voxel-based morphometry to discriminate early Alzheimer's disease from controls
Hirata, Y., Matsuda, H., Nemoto, K., Ohnishi, T., Hirao, K., Yamashita, F., Asada, T., Iwabuchi, S., & Samejima, H. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2005.03.038 · Cited by 329
Neurogenesis and Alzheimer's disease: At the crossroads
Lazarov, O., & Marr, R. A. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.08.009 · Cited by 340
Lazarov, O., Lee, M., Peterson, D. A., & Sisodia, S. S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-22-09785.2002 · Cited by 302
Stricker, N. H., Schweinsburg, B. C., Delano‐Wood, L., Wierenga, C. E., Bangen, K. J., Haaland, K. Y., Frank, L. R., Salmon, D. P., & Bondi, M. W. (2008) · NeuroImage · doi:10.1016/j.neuroimage.2008.11.027 · Cited by 318
Regional rates of neocortical atrophy from normal aging to early Alzheimer disease
McDonald, C. R., McEvoy, L. K., Gharapetian, L., Fennema-Notestine, C., Hagler, D. J., Holland, D., Koyama, A., Brewer, J. B., & Dale, A. M. (2009) · Neurology · doi:10.1212/wnl.0b013e3181b16431 · Cited by 299
Wu, Y., Feenstra, M. G. P., Zhou, J., Liu, R., Toraño, J. S., van Kan, H. J. M., Fischer, D. F., Ravid, R., & Swaab, D. F. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030833 · Cited by 284
Lerch, J. P., Pruessner, J. C., Zijdenbos, A. P., Collins, D. L., Teipel, S. J., Hampel, H. J., & Evans, A. C. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.09.013 · Cited by 281
Small, S. A., Chawla, M. K., Buonocore, M. H., Rapp, P. R., & Barnes, C. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400285101 · Cited by 281
Safety and biomarker effects of solanezumab in patients with Alzheimer's disease
Farlow, M. R., Arnold, S. E., van Dyck, C. H., Aisen, P. S. S., Snider, B. J., Porsteinsson, A. P., Friedrich, S. W., Dean, R. A., Gonzales, C., Sethuraman, G., et al. (2012) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2011.09.224 · Cited by 285
Zhou, J., Liu, R., Kamphorst, W., Hofman, M. A., & Swaab, D. F. (2003) · Journal of Pineal Research · doi:10.1034/j.1600-079x.2003.00065.x · Cited by 269
Better Memory and Neural Efficiency in Young Apolipoprotein E 4 Carriers
Mondadori, C. R. A., de Quervain, D. J. ‐., Buchmann, A., Mustovic, H., Wollmer, M. A., Schmidt, C. F., Boesiger, P., Hock, C., Nitsch, R. M., Papassotiropoulos, A., et al. (2006) · Cerebral Cortex · doi:10.1093/cercor/bhl103 · Cited by 277
Desai, M. K., Sudol, K. L., Janelsins, M. C., Mastrangelo, M. A., Frazer, M. E., & Bowers, W. J. (2009) · Glia · doi:10.1002/glia.20734 · Cited by 266
Dissociating atrophy and hypometabolism impact on episodic memory in mild cognitive impairment
Chetelat, G. (2003) · Brain · doi:10.1093/brain/awg196 · Cited by 264
Memory encoding in Alzheimer's disease: an fMRI study of explicit and implicit memory
Golby, A. J. (2005) · Brain · doi:10.1093/brain/awh400 · Cited by 260
Proteomic landscape of Alzheimer’s Disease: novel insights into pathogenesis and biomarker discovery
Bai, B., Vanderwall, D., Li, Y., Wang, X., Poudel, S., Wang, H., Dey, K. K., Chen, P., Yang, K., & Peng, J. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00474-z · Cited by 267
Brickman, A. M., Zahodne, L. B., Guzman, V. A., Narkhede, A., Meier, I. B., Griffith, E. Y., Provenzano, F. A., Schupf, N., Manly, J. J., Stern, Y., et al. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.07.019 · Cited by 265
Tau immunotherapy for Alzheimer's disease
Pedersen, J. T., & Sigurdsson, E. M. (2015) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2015.03.003 · Cited by 247
Muhammad, A., Flores, I., Zhang, H., Yu, R., Staniszewski, A., Planel, E., Herman, M., Ho, L., Kreber, R., Honig, L. S., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802545105 · Cited by 248
Tesseur, I. C., Dorpe, J. V., Spittaels, K., den Haute, C. V., Moechars, D., & LEUVEN, F. V. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64963-2 · Cited by 239
Phonological dyslexia and dysgraphia: Cognitive mechanisms and neural substrates
Rapcsak, S. Z., Beeson, P. M., Henry, M. L., Leyden, A., Kim, E., Rising, K., Andersen, S., & Cho, H. (2008) · Cortex · doi:10.1016/j.cortex.2008.04.006 · Cited by 243
Beta‐amyloid deposition and the aging brain
Rodrigue, K. M., Kennedy, K. M., & Park, D. C. (2009) · Neuropsychology Review · doi:10.1007/s11065-009-9118-x · Cited by 230
Regionally-specific diffusion tensor imaging in mild cognitive impairment and Alzheimer’s disease.
Mielke, M. M., Kozauer, N. A., Chan, K. C. G., George, M., Toroney, J., Zerrate, M., Bandeen-Roche, K., Wang, M.-C., vanZijl, P., & Pekar, J. J. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2009.01.054 · Cited by 225
Grothe, M. J., Záborszky, L., Atienza, M., Gil-Neciga, E., Rodriguez‐Romero, R., Teipel, S., Amunts, K., Gonzalez, A. S., & Cantero, J. L. (2009) · Cerebral Cortex · doi:10.1093/cercor/bhp232 · Cited by 223
β‐amyloid burden is not associated with rates of brain atrophy
Josephs, K. A., Whitwell, J. L., Ahmed, Z., Shiung, M. M., Weigand, S. D., Knopman, D. S., Boeve, B. F., Parisi, J. E., Petersen, R. C., Dickson, D. W., et al. (2007) · Annals of Neurology · doi:10.1002/ana.21223 · Cited by 240
Pereira, J. B., Ibarretxe‐Bilbao, N., Martı́, M. J., Compta, Y., Junqué, C., Bargalló, N., & TOLOSA, E. S. (2011) · Human Brain Mapping · doi:10.1002/hbm.21378 · Cited by 234
Burggren, A. C., Zeineh, M., Ekstrom, A. D., Braskie, M. N., Thompson, P. M., Small, G. W., & Bookheimer, S. Y. (2008) · NeuroImage · doi:10.1016/j.neuroimage.2008.03.039 · Cited by 225
Selective decline in memory function among healthy elderly
Small, S. A., Stern, Y., Tang, M. X., & Mayeux, R. P. (1999) · Neurology · doi:10.1212/wnl.52.7.1392 · Cited by 218
MicroRNA: Implications for Alzheimer Disease and other Human CNS Disorders
Maes, O. C., Chertkow, H. M., Wang, E., & Schipper, H. M. (2009) · Current Genomics · doi:10.2174/138920209788185252 · Cited by 223
Hellström‐Lindahl, E., Mousavi, M. T., Zhang, X., Ravid, R., & Nordberg, A. K. (1999) · Molecular Brain Research · doi:10.1016/s0169-328x(99)00030-3 · Cited by 215
Mielke, M. M., Okonkwo, O. C., Oishi, K., Mori, S., Tighe, S. K., Miller, M. I., Ceritoglu, C., Brown, T., Albert, M., & Lyketsos, C. G. (2012) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2011.05.2416 · Cited by 220
Magnetic resonance spectroscopy in cognitive research
Ross, A. J., & Sachdev, P. S. (2004) · Brain Research Reviews · doi:10.1016/j.brainresrev.2003.11.001 · Cited by 206
Subregional neuroanatomical change as a biomarker for Alzheimer's disease
Holland, D., Brewer, J. B., Hagler, D. J., Fennema-Notestine, C., Dale, A. M., Initiative, T. A. D. N., Weiner, M., Thal, L., Petersen, R., Jack, C. R., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0906053106 · Cited by 210
Synphilin-1 is present in Lewy bodies in Parkinson's disease
Wakabayashi, K., Engelender, S., Yoshimoto, M., Tsuji, S., Ross, C. A., & Takahashi, H. (2000) · Annals of Neurology · doi:10.1002/1531-8249(200004)47:4 · Cited by 269
Im, K., Lee, J. M., Seo, S. W., Kim, S. H., Kim, S. I., & Na, D. L. (2008) · NeuroImage · doi:10.1016/j.neuroimage.2008.07.016 · Cited by 207
Raj, A., LoCastro, E., Kuceyeski, A. F., Tosun, D., Relkin, N. R., & Weiner, M. W. (2015) · Cell Reports · doi:10.1016/j.celrep.2014.12.034 · Cited by 210
Imaging hippocampal function across the human life span: Is memory decline normal or not?
Small, S. A., Tsai, W. Y., DeLaPaz, R., Mayeux, R., & Stern, Y. (2002) · Annals of Neurology · doi:10.1002/ana.10105 · Cited by 205
Resilience to autosomal dominant Alzheimer’s disease in a Reelin-COLBOS heterozygous man
Lopera, F., Marino, C., Chandrahas, A. S., O’Hare, M., Villalba-Moreno, N. D., Aguillon, D., Baena, A., Sanchez, J. S., Vila-Castelar, C., Ramirez Gomez, L., et al. (2023) · Nature Medicine · doi:10.1038/s41591-023-02318-3 · Cited by 192
Neurofibrillary tangles in nondemented elderly subjects and mild Alzheimer disease
Haroutunian, V., Purohit, D. P., Perl, D. P., Marin, D., Khan, K., Lantz, M., Davis, K. L., & Mohs, R. C. (1999) · Archives of Neurology · doi:10.1001/archneur.56.6.713 · Cited by 201
Temporal lobe functional activity and connectivity in young adult APOE ɛ4 carriers
Dennis, N. A., Browndyke, J. N., Stokes, J., Need, A., Burke, J. R., Welsh‐Bohmer, K. A., & Cabeza, R. (2010) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2009.07.003 · Cited by 201
Wong, T. P., Debeir, T., Duff, K., & Cuello, A. C. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-07-02706.1999 · Cited by 196
Neurogenetic contributions to amyloid beta and tau spreading in the human cortex
Sepulcre, J., Grothe, M. J., Uquillas, F. D., Ortiz-Terán, L., Diez, I. P., Yang, H., Jacobs, H. I. L., Hanseeuw, B. J., Li, Q., Fakhri, G. E., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0206-4 · Cited by 195
Tau-Centric targets and drugs in clinical development for the treatment of alzheimer's disease
Panza, F., Solfrizzi, V., Seripa, D., Imbimbo, B. P., Lozupone, M., Santamato, A., Zecca, C., Barulli, M. R., Bellomo, A., Pilotto, A., et al. (2016) · BioMed Research International · doi:10.1155/2016/3245935 · Cited by 195
Siemers, E., Friedrich, S. W., Dean, R. A., Gonzales, C., Farlow, M. R., Paul, S. M., & Demattos, R. B. (2010) · Clinical Neuropharmacology · doi:10.1097/wnf.0b013e3181cb577a · Cited by 192
Haider, F., García, S. D. L. F., & Luz, S. F. (2019) · IEEE Journal of Selected Topics in Signal Processing · doi:10.1109/jstsp.2019.2955022 · Cited by 204
VAN HOESEN, G. W., AUGUSTINACK, J. C., DIERKING, J., REDMAN, S. J., & THANGAVEL, R. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06731.x · Cited by 211
Greenwood, P. M., Lambert, C., Sunderland, T., & Parasuraman, R. (2005) · Neuropsychology · doi:10.1037/0894-4105.19.2.199 · Cited by 188
Challis, E., Hurley, P. D., Serra, L., Bozzali, M., Oliver, S., & Cercignani, M. (2015) · NeuroImage · doi:10.1016/j.neuroimage.2015.02.037 · Cited by 186
Increased Neurofibrillary Tangles in Patients With Alzheimer Disease With Comorbid Depression
Rapp, M. A., Beeri, M. S., Purohit, D. P., Perl, D. P., Haroutunian, V. H., & Sano, M. C. (2008) · American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e31816029ec · Cited by 181
Small, S. A. (2001) · Archives of Neurology · doi:10.1001/archneur.58.3.360 · Cited by 183
Cognitive Training Changes Hippocampal Function in Mild Cognitive Impairment: A Pilot Study
Rosen, A. C., Sugiura, L., Kramer, J. H., Whitfield, S., & Gabrieli, J. D. E. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-0009 · Cited by 180
Babiloni, C., Carducci, F., Lizio, R., Vecchio, F., Baglieri, A., Bernardini, S., Cavedo, E., Bozzao, A., Buttinelli, C., Esposito, F., et al. (2012) · Human Brain Mapping · doi:10.1002/hbm.22005 · Cited by 175
Familial risk for Alzheimer's disease alters fMRI activation patterns
Bassett, S. S., Yousem, D. M., Cristinzio, C., Kusevic, I., Yassa, M. A., Caffo, B. S., & Zeger, S. L. (2006) · Brain · doi:10.1093/brain/awl089 · Cited by 174
Rates of cerebral atrophy differ in different degenerative pathologies
Whitwell, J. L., Jack, C. R., Parisi, J. E., Knopman, D. S., Boeve, B. F., Petersen, R. C., Ferman, T. J., Dickson, D. W., & Josephs, K. A. (2006) · Brain · doi:10.1093/brain/awm021 · Cited by 174
Testing the white matter retrogenesis hypothesis of cognitive aging
Brickman, A. M., Meier, I. B., Korgaonkar, M. S., Provenzano, F. A., Grieve, S. M., Siedlecki, K. L., Wasserman, B. T., Williams, L. M., & Zimmerman, M. E. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.06.001 · Cited by 177
Hu, Y., Xu, P., Pigino, G. F., Brady, S. T., Larson, J., & Lazarov, O. (2010) · The FASEB Journal · doi:10.1096/fj.09-136945 · Cited by 176
Tau Oligomers: The Toxic Player at Synapses in Alzheimer’s Disease
Guerrero-Muñoz, M. J., Gerson, J., & Castillo-Carranza, D. L. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00464 · Cited by 168
Preclinical Alzheimer disease: Neuropsychological test performance 1.5 to 8 years prior to onset
Saxton, J., Lopez, O. L., Ratcliff, G., Dulberg, C., Fried, L. P., Carlson, M. C., Newman, A. B., & Kuller, L. (2004) · Neurology · doi:10.1212/01.wnl.0000147470.58328.50 · Cited by 168
Olfactory deficit detected by fMRI in early Alzheimer's disease
Wang, J., Eslinger, P. J., Doty, R. L., Zimmerman, E. K., Grunfeld, R., Sun, X., Meadowcroft, M. D., Connor, J. R., Price, J. L., Smith, M. B. H., et al. (2010) · Brain Research · doi:10.1016/j.brainres.2010.08.018 · Cited by 175
Potential Effects of MSC-Derived Exosomes in Neuroplasticity in Alzheimer’s Disease
Reza-Zaldívar, E. E., Hernández-Sapiéns, M. A., Minjarez, B. D., Gutiérrez-Mercado, Y. K., Márquez-Aguirre, A. L., & Canales-Aguirre, A. A. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00317 · Cited by 169
Carlesimo, G. A., Piras, F., Orfei, M. D., Iorio, M., Caltagirone, C., & Spalletta, G. (2015) · Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring · doi:10.1016/j.dadm.2014.12.001 · Cited by 159
Wolf, H., Grunwald, M., Kruggel, F., Riedel-Heller, S. G., Angerhöfer, S., Hojjatoleslami, A., Hensel, A., Arendt, T., & Gertz, H.-J. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00238-4 · Cited by 164
Cholinesterase inhibitors in the treatment of dementia.
Ellis, J. M. (2005) · PubMed · Cited by 161
Metadata
- Authors
- Braak, H., & Braak, E.
- Affiliations
- Goethe University Frankfurt (DE)
- Corresponding author
- Braak, H.
- ORCID
- Braak, H.
- Venue
- Acta Neurologica Scandinavica
- Publisher
- Wiley
- Published
- 1996-04
- Volume
- 94
- Issue
- S165
- Pages
- 3-12
- ISSN
- 0001-6314 (ISSN-L)
- OpenAlex
- W1971744915
- Cited by
- 710
- References
- 53
- Citations by year
- 2026: 13 · 2025: 24 · 2024: 27 · 2023: 22 · 2022: 29 · 2021: 22 · 2020: 29 · 2019: 27 · 2018: 29 · 2017: 25 · 2016: 31 · 2015: 36 · 2014: 36 · 2013: 31 · 2012: 36
- FWCI
- 2.02
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Acta Neurologica Scandinavica (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Deutsche Forschungsgemeinschaft
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Alzheimer's disease, neuropathology, amyloid plaques, tau protein, neurofibrillary tangles, entorhinal cortex, cortical atrophy, disease stage, etiopathogenesis
- MeSH terms
- Alzheimer Disease, Hippocampus, Humans, Neurofibrillary Tangles, Entorhinal Cortex
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review